Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional Results available

A Study to Test the Efficacy and Safety of Inhaled GB0139 in Subjects With Idiopathic Pulmonary Fibrosis (IPF)

ClinicalTrials.gov ID: NCT03832946

Public ClinicalTrials.gov record NCT03832946. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Sep 27, 2026, 5:06 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Randomized, 52 Week, Double-blind, Multicentre, Parallel, Placebo-controlled Phase 2b Study in Subjects With Idiopathic Pulmonary Fibrosis (IPF) Investigating the Efficacy and Safety of GB0139, an Inhaled Galectin-3 Inhibitor.

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This is a randomized, double-blind, placebo-controlled phase 2b trial in subjects with IPF (idiopathic pulmonary fibrosis) investigating the efficacy and safety of GB0139.

Study identification

NCT ID
NCT03832946
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Galecto Biotech AB
Industry
Enrollment
172 participants

Conditions and interventions

Interventions

Drug

Eligibility (public fields only)

Age range
40 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Feb 18, 2019
Primary completion
May 16, 2023
Completion
May 16, 2023
Last update posted
May 21, 2024

2019 – 2023

United States locations

U.S. sites
34
U.S. states
21
U.S. cities
32
Facility City State ZIP Site status
SEC Clinical Research Andalusia Alabama 36420-5310 —
Jasper Summit Research, LLC Pulmonary & Sleep Associates Jasper Alabama 35501 —
Palmtree Clinical Research Inc Palm Springs California 92262-4871 —
Paradigm Research Redding California 96001-0172 —
Yale University School of Medicine New Haven Connecticut 06520-8057 —
Health Shands Hospital Gainesville Florida 32611 —
Harmony Medical Research Institute, Inc Hialeah Florida 33016 —
Advanced Research for Health Improvement Naples Florida 34109 —
Broward Research Centre Pembroke Pines Florida 33024 —
Avanza Medical Research Centre Pensacola Florida 32503 —
Coastal Pulmonary Critical Care PLC St. Petersburg Florida 33704 —
Tampa General Hospital/Uni Florida Tampa Florida 33606 —
Piedmont Healthcare Pulmonary and Critical Care Research Atlanta Georgia 30309 —
The Emory Clinic Atlanta Georgia 30322 —
DC Research Works Marietta Georgia 30060-7297 —
Northwestern Memorial Hospital Chicago Illinois 97232 —
LaPorte County Institute for Clinical Research Michigan City Indiana 46360-9330 —
University of Kansas Medical Centre Kansas City Kansas 66160 —
University of Louisville Hospital Louisville Kentucky 40202 —
University of Maryland Baltimore Maryland 21201 —
Harvard Medical School - Brigham and Womens Hospital (BWH) Boston Massachusetts 02115 —
The Lung Research Center LLC Chesterfield Missouri 63017 —
Dartmouth-Hitchcock Medical Center Lebanon New Hampshire 03766 —
Pulmonlx LLC Greensboro North Carolina 27403 —
University of Cincinnati Cincinnati Ohio 45276 —
The Cleveland Clinic Foundation Cleveland Ohio 44109 —
Thomas Jefferson University Philadelphia Pennsylvania 19107 —
Vanderbilt University Medical Center Nashville Tennessee 37232-2650 —
University of Texas Health Centre at Houston Houston Texas 77030 —
University of Texas Health Sciences Center at Houston Houston Texas 77030 —
Diagnostics Research Group San Antonio Texas 78229 —
University of Utah Health Scieces Center Salt Lake City Utah 84108 —
TPMG Clinical Research Williamsburg Virginia 23188 —
Medical College of Wisconsin Milwaukee Wisconsin 53226 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 94 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT03832946, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted May 21, 2024 · Synced Sep 27, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT03832946 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →